Talcott Resolution Life Insurance Co. Separate Account 11

12/17/2025 | Press release | Distributed by Public on 12/17/2025 11:22

Prospectus by Investment Company (Form 497)

Rule 497(e)
File Nos. 333-72042; 811-10559
TALCOTT RESOLUTION LIFE INSURANCE COMPANY
SEPARATE ACCOUNT ELEVEN
HV-3574 - PremierSolutions Standard
HV-4899 - PremierSolutions New Jersey Institutions of Higher Education
HV-5244 - PremierSolutions Standard (Series II)
HV-5776 - PremierSolutions Cornerstone
HV-5795 - PremierSolutions Standard (Series A)
HV-6775 - PremierSolutionsCornerstone (Series II)
HV-6779 - PremierSolutions Standard (Series A-II)
Supplement datedDecember 17, 2025 to Prospectuses dated May 1, 2025
Effective December 1, 2025, the following funds in the above-referenced prospectuses, as applicable, were renamed as follows:
Macquarie Asset Strategy Fundwas renamed Nomura Asset Strategy Fund.
Macquarie Diversified Income Fund was renamed Nomura Diversified Income Fund.
Macquarie Extended Duration Bond Fund was renamedNomura Extended Duration Bond Fund.
Macquarie Large Cap Growth Fund was renamed Nomura Large Cap Growth Fund.
Macquarie Natural Resources Fund was renamed Nomura Natural Resources Fund.
Macquarie Science and Technology Fundwas renamed Nomura Science and Technology Fund.
Macquarie Small Cap Growth Fundwas renamed Nomura Small Cap Growth Fund.
Effective December 1, 2025, the following were removed as sub-advisers to the above-referenced funds, as applicable:
Macquarie Investment Management Austria Kapitalanlage AG
Macquarie Investment Management Europe Limited
Macquarie Investment Management Global Limited
Please read this Supplement carefully and retain it for future reference.
2025-PROSUPP-35
Talcott Resolution Life Insurance Co. Separate Account 11 published this content on December 17, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 17, 2025 at 17:22 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]